Novasorb ® Cationic Nanoemulsion and Latanoprost: The Ideal Combination for Glaucoma Management?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-01-26

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.35248/2684-1622.17.2.107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping

  2016cited by this paper
• Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease: A Multicenter Randomized Trial

  2016cited by this paper
• Surface chemistry of the interactions of cationic nanoemulsions with human meibum films

  2016cited by this paper
• Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye.

  2016cited by this paper
• Efficacy and Safety of a Cationic Emulsion in the Treatment of Moderate to Severe Dry Eye Disease: A Randomized Controlled Study

  2016cited by this paper
• Mechanism of action of cationic emulsions in the management of ocular surface inflammation and wound healing

  2016cited by this paper
• Patient satisfaction with glaucoma therapy: reality or myth?

  2015cited by this paper
• The real reason for having a meibomian lipid layer covering the outer surface of the tear film - A review.

  2015cited by this paper
• Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study.

  2015cited by this paper
• The precorneal tear film as a fluid shell: the effect of blinking and saccades on tear film distribution and dynamics.

  2014cited by this paper
• Ocular Surface Disease Exacerbated Glaucoma: Optimizing the Ocular Surface Improves Intraocular Pressure Control

  2014influential reference
• The effect of preservatives and antiglaucoma treatments on the ocular surface of mice with dry eye.

  2014cited by this paper
• Distribution of Cyclosporine A in Ocular Tissues After Topical Administration of Cyclosporine A Cationic Emulsions to Pigmented Rabbits

  2013cited by this paper
• Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery

  2013cited by this paper
• Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls.

  2013cited by this paper
• Evaluation of Lipid Layer Thickness Measurement of the Tear Film as a Diagnostic Tool for Meibomian Gland Dysfunction

  2013cited by this paper
• Comparison of a Travoprost BAK-Free Formulation Preserved with Polyquaternium-1 with BAK-Preserved Travoprost in Ocular Hypertension or Open-Angle Glaucoma

  2012cited by this paper
• A Comparative Study of a Preservative-Free Latanoprost Cationic Emulsion (Catioprost) and a BAK-Preserved Latanoprost Solution in Animal Models

  2012cited by this paper
• Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb

  2012cited by this paper
• In Vitro and In Vivo Evaluation of a Preservative-Free Cationic Emulsion of Latanoprost in Corneal Wound Healing Models

  2012cited by this paper
• Wound Healing Models

  2011cited by this paper
• Altered morphology and function of the lacrimal functional unit in protein kinase C{alpha} knockout mice.

  2010cited by this paper
• Preservatives in eyedrops: the good, the bad and the ugly.

  2010cited by this paper
• Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications

  2010cited by this paper
• Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost

  2010cited by this paper
• Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay

  2009cited by this paper
• Glycan structures of ocular surface mucins in man, rabbit and dog display species differences

  2008cited by this paper
• Prevalence of Ocular Surface Disease in Glaucoma Patients

  2008cited by this paper
• The correlation between the tear film lipid layer and dry eye disease.

  2007influential reference
• Lymphocyte function-associated antigen-1-dependent inhibition of corneal wound healing.

  2006cited by this paper
• The controlled-environment chamber: a new mouse model of dry eye.

  2005cited by this paper
• Accelerated wound healing of alkali-burned corneas in MRL mice is associated with a reduced inflammatory signature.

  2005cited by this paper
• Correlation of lipid layer thickness measurements with fluorescein tear film break-up time and Schirmer's test

  2003influential reference
• Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication

  2002cited by this paper
• Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye.

  1996influential reference
• Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.

  1995cited by this paper

• Fifteen-Month Outcomes of Preservative-Free Latanoprost Cationic Emulsion in Open-Angle Glaucoma and Ocular Hypertension: Phase III Open-Label Extension of a Randomized Trial

  2025cites this paper
• A phase III study comparing preservative-free latanoprost eye drop emulsion with preserved latanoprost in open-angle glaucoma or ocular hypertension

  2025influential citation
• Oil-in-water nanoemulsions for glaucoma treatment: An insight into the latest trends

  2024cites this paper
• Use of a Cationic Emulsion of Latanoprost to Treat Glaucoma Patients with Ocular Surface Disease: A Preclinical Review

  2023cites this paper
• Lipid-based nanocarriers challenging the ocular biological barriers: Current paradigm and future perspectives.

  2023cites this paper
• Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy—An Overview on Recent Advances

  2022cites this paper
• Cost–Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany

  2022influential citation
• Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France

  2022cites this paper
• OPTH_A_351013 323..337

  2022influential citation
• Aqueous Prostaglandin Eye Drop Formulations

  2022cites this paper
• A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis

  2022cites this paper
• Perspectives of Molecularly Imprinted Polymer-Based Drug Delivery Systems in Ocular Therapy

  2021cites this paper
• Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

  2021cites this paper
• Ballistic delivery of compounds to inner layers of the cornea is limited by tough mechanical properties of stromal tissue.

  2020cites this paper
• Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery.

  2020cites this paper
• Insight of Eye Diseases and Disorders

  2020cites this paper
• Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities.

  2020cites this paper
• Emerging Trends in Ocular Drug Delivery: A Review on Recent Updates

  2017cites this paper
• Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions

  2017cites this paper